Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study have?
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study has 9 citations in the OpenAlex counts ScholarIQ stores.
When was Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study published?
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study has 2021 year in the ScholarIQ index.
What is the open-access status of Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study?
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study has hybrid oa status in the ScholarIQ index.
What is the DOI of Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study?
The DOI for Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study is on the source record.
What is the PMID of Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study?
The PMID for Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study is on the source record.
What is the OpenAlex record for Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study?
The OpenAlex for Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study is on the source record.